News
Tower Mains Monthly Newsletter – May 2026
Company News ICH GCP E6 (R3) has officially come into effect in the UK, bringing a stronger focus on risk-based approaches, data integrity, and modern trial delivery. These changes will shape how clinical trials are designed, managed, and inspected. To help organisations understand the practical impact, we’ve launched [...]
25 Key Learnings from Exhibiting at GxP Conferences
As our conference season kicks off, we’re looking forward to connecting with quality professionals across the industry and hearing first-hand about the challenges, priorities, and opportunities shaping the GxP landscape. Whether through discussions at our exhibition stand or topics raised during workshops, presentations, and panel sessions, many of the same issues continue to surface across [...]
Tower Mains Monthly Newsletter – April 2026
Company News We're delighted to be exhibiting at the 42nd Society of Quality Assurance Annual Meeting in National Harbor, Washington DC this month! Bringing together over 800 QA professionals from around the world, the meeting will explore key hot topics including GCP, GLP, GMP, pharmacovigilance, scientific archiving, computer [...]
25 Common Data Integrity Findings
Data integrity is often talked about in terms of systems, controls, and regulations. In reality, it’s about people, culture, and how day-to-day processes are carried out. Across GLP, GCP, GMP, and PV in clinical trials, the same patterns keep showing up – different domains, same underlying issues. Below [...]
Tower Mains Monthly Newsletter – March 2026
Regulatory News FDA Launches PreCheck Pilot to Strengthen US Pharmaceutical Manufacturing On 1st February, the FDA launched the PreCheck pilot program, designed to strengthen the domestic pharmaceutical supply chain by providing earlier regulatory engagement and streamlined assessments for new US manufacturing facilities. The initiative aims to encourage domestic [...]
25 Things Learned from 25 Years of GxP Audits
Auditing is often perceived as a technical exercise built around checklists and findings. In reality, it is far more nuanced and human, shaped by preparation, communication, judgment, and an ability to understand how systems operate in practice, not just on paper. This month, as part of our 25 [...]
Tower Mains Monthly Newsletter – February 2026
Regulatory News EMA and FDA Set Common Principles for AI Use in Medicine Development On 14th January, the European Medicines Agency (EMA) and the FDA jointly issued a set of ten guiding principles for the responsible use of artificial intelligence (AI) in drug development. These principles provide broad guidance [...]
It’s Our Birthday: Tower Mains Turns 25!
This year, we celebrate 25 remarkable years! To kick off our 25 Years of Tower Mains series, we’re taking a nostalgic look back at 2001 – the year it all began – when flip phones were everywhere, internet connections tested our patience, and the technology we now rely [...]
Tower Mains Monthly Newsletter – January 2026
Celebrating 25 Years of Quality, Continuity and Trust This year marks a major milestone for Tower Mains as we celebrate 25 years of supporting the global scientific community. From the outset, our approach has been shaped by what customers told us mattered most: access to trusted, end-to-end quality [...]
Tower Mains Monthly Newsletter – December 2025
Company News Begin your GxP Journey with Our Essentials Course Whether you're entering a GxP-regulated environment for the first time or just interested to know a bit about what is out there, GxP Essentials equips you with the foundations you need to work confidently, competently, and compliantly. In [...]
